The Oncology Institute to Participate at Upcoming Investor Conferences
May 31 2023 - 7:00AM
The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest
value-based oncology groups in the United States, today announced
that senior management will participate at the following investor
conferences:
2023 Jefferies Healthcare ConferenceDate: June 9th, 2023Fireside
Chat: 11:00am Eastern TimeTOI Participant: Daniel Virnich, M.D.,
MBA, PresidentLocation: New York City, NY
UBS Healthcare Services ConferenceDate: June 26th – 28th,
2023TOI Participant: Brad Hively, Chief Executive OfficerLocation:
Chatham, MA
Interested investors and other parties may listen to
simultaneous webcasts of the presentations by logging onto the
Investor Relations section of the Company’s website at
https://investors.theoncologyinstitute.com/. The online replay will
be available for a limited time shortly following the call.
About The Oncology Institute, Inc.
Founded in 2007, TOI is advancing oncology by delivering highly
specialized, value-based cancer care in the community setting. TOI
offers cutting-edge, evidence-based cancer care to a population of
approximately 1.8 million patients including clinical trials,
transfusions, and other services traditionally associated with the
most advanced care delivery organizations. With 100+ employed
clinicians and more than 700 teammates in over 60 clinic locations
and growing, TOI is changing oncology for the better. For more
information visit www.theoncologyinstitute.com.
Contacts
Media
The Oncology Institute, Inc.Daniel Virnich,
MDdanielvirnich@theoncologyinstitute.com(562) 735-3226 x 81125
Investors
Solebury Strategic
Communicationsinvestors@theoncologyinstitute.com
Oncology Institute (NASDAQ:TOIIW)
Historical Stock Chart
From Apr 2024 to May 2024
Oncology Institute (NASDAQ:TOIIW)
Historical Stock Chart
From May 2023 to May 2024